Publication | Closed Access

Changes in serum levels of miR-21, miR-210, and miR-373 in HER2-positive breast cancer patients undergoing neoadjuvant therapy: a translational research project within the Geparquinto trial

Tumor BiologyBreast OncologyMedicineGeparquinto TrialTranslational Research ProjectPathologyBreast CancerMicrorna DetectionOncologyRadiation OncologyCancer ResearchSerum Levels